Evidence map›Paper›PMID 41969590›Full record

ArticleJournal of research in pharmacy practice2026

Patients' Needs and Expectations for the Application of Prevention of Drug-related Problems Prevention Programs.

Ainhoa Vilarrubias Llopis, Jesús Ruiz-Ramos, Adrián Plaza Díaz, Mireia Puig Campmany, Anna Buisan Álvarez, Caterina Sampol-Mayol, Ana Juanes-Borrego

Abstract read
In one paragraph

Article in Journal of research in pharmacy practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ainhoa Vilarrubias LlopisUser Experience Office Strategy, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Jesús Ruiz-RamosPharmacy Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Adrián Plaza DíazPharmacy Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Mireia Puig CampmanyPharmacy Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Anna Buisan ÁlvarezUser Experience Office Strategy, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Caterina Sampol-MayolMés Sant Pau Office, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Ana Juanes-BorregoPharmacy Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Drug-related problems (DRPs) constitute a relevant health issue with a significant and escalating impact. The objective of this study is to identify the needs and expectations of patients benefiting from secondary prevention programs for DRPs in an emergency department. Methods: A 7-month prospective study was conducted. Three participatory sessions were held with professionals from different healthcare levels, along with individual interviews conducted with patients and their caregivers and healthcare professionals involved. The concepts around which the analysis was centered on the journey maps of each user of a secondary prevention program of DRPs and the problems, needs, and opportunities for improvement in various scenarios, including primary care, hospitals, residences, intermediate care, and community pharmacies. Findings: A total of 40 interviews were conducted to define the scenarios in which the patient can travel in the healthcare environment. Patients identified problems after hospital discharge, expressing the desire to have more time with the healthcare professional to comprehend, and integrate the information about their treatment. Similarly, difficulties arose in resolving doubts because there was no contact person available after discharge. The healthcare settings of primary care and community pharmacy play important roles in instilling confidence in users. Conclusion: Patients engaging in DRP's prevention programs require a redefined healthcare team to manage their medications. This team should have clearly defined roles among professionals and implement a follow-up and reinforcement program to personalize treatment adjusting medication (medication changes), educating patients through guidelines to enhance patient's adherence.

Indexed as

Drug-related side effects and adverse reactionsfrailtymedication adherence

Identifiers

PMID41969590
PMCPMC13067957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.